Skip to main content
Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.97
+0.20 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Pelthos Therapeutics Revenue

In the year 2025, Pelthos Therapeutics had annual revenue of $16.80M. Pelthos Therapeutics had revenue of $9.39M in the quarter ending December 31, 2025.

Revenue (ttm)
$16.80M
Revenue Growth
n/a
P/S Ratio
4.99
Revenue / Employee
$182,554
Employees
92
Market Cap
83.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202516.80M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Q32 Bio 53.74M
Gossamer Bio 48.47M
Sangamo Therapeutics 39.55M
TScan Therapeutics 10.33M
Alterity Therapeutics 4.43M
Revenue Rankings

PTHS News

More News